US Patent 10265382 Complexes of IL-15 and IL-15Ralpha and uses thereof
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+510 characters)
Article
Patent abstract
The present invention relates to agents that modulate interleυkin-15 (“IL-15”) signal transduction or function (“Therapeutic Agents”) and the use ol” those agents to modulate immune function. The Therapeutic Agents target the interaction between IL-15 and its receptor and modulate IL-15-induced signal transduction. The Therapeutic Agents may be formulated with polymers, such as poly-β-1-♦4-N-acetylglucosamine. for administration to a human subject to modulate IL-15-mediated immune function.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
102653820
Date of Patent
April 23, 2019
0Patent Application Number
154246210
Date Filed
February 3, 2017
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
102653820
Date of Patent
April 23, 2019
0Patent Application Number
154246210
Date Filed
February 3, 2017
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10265382 Complexes of IL-15 and IL-15Ralpha and uses thereof
Infobox
Is a
Patent jurisdiction
Patent number
10265382
Date of patent
April 23, 2019
Patent application number
15424621
Date Filed
February 3, 2017
Patent primary examiner
Find more entities like US Patent 10265382 Complexes of IL-15 and IL-15Ralpha and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.